ArticleCureus2025
Ganglion Impar Block and Pulsed Radiofrequency Under Fluoroscopic Guidance in Chronic Coccydynia: A Retrospective Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Chronic coccydynia is characterized by persistent pain in the coccygeal region and can significantly impair functionality and quality of life. While most patients respond to conservative treatments, some experience refractory pain that may benefit from minimally invasive interventions, such as ganglion impar block and/or pulsed radiofrequency (PRF). This study aims to investigate the effectiveness and safety of fluoroscopy-guided ganglion impar block and/or PRF in patients with chronic coccydynia refractory to conservative treatments. Methods We conducted a retrospective case series involving 24 patients with coccydynia lasting at least three months, who underwent ganglion impar block and/or PRF between 2021 and 2025. Clinical data - namely, demographics, comorbidities, history of trauma, vaginal delivery or tumours, sacrococcygeal joint dysfunction, and pain intensity measured with the Numerical Rating Scale (NRS) before and at one, three, and six months post-procedure - were collected and analysed descriptively. Results Our case series included 24 patients (91.7% females), who were naïve to minimally invasive treatments for coccydynia, with a mean age of 46.1 ± 15.9 years and a mean BMI of 24.2 ± 5.3 kg/m². Of the total 24 patients, 14 (58.3%) underwent a ganglion impar block. These patients presented a baseline mean NRS of 8.4 ± 1.4 and reported a mean pain reduction of 64% at one month after the procedure, 60% at three months, and 50% at six months. On the other hand, 10 (41.7%) patients were submitted to PRF of the ganglion impar after an immediate positive response to the ganglion impar block. These patients presented a baseline mean NRS of 8.5 ± 1.4 and yielded mean pain reductions of 73% at one month, 62% at three months, and 49% at six months. Three (12.5%) patients with comorbid anxiety and depression experienced meaningful pain relief, regardless of the procedure performed. Patients whose severe coccydynia returned after initial relief underwent repeat ganglion impar block or PRF; repeated procedures showed diminished efficacy, with lower pain relief observed at six months compared to the initial intervention (mean pain reductions of 21% and 38% at six months, respectively). All interventions were performed safely, with no reported complications. Conclusion Fluoroscopy-guided ganglion impar block and PRF appear to be safe and effective initial interventions for managing chronic coccydynia refractory to conservative treatment. Our data demonstrated clinically meaningful and similar pain relief for up to six months with both procedures. Modest pain relief was observed with repeated ganglion impar block or PRF. Further research with larger patient cohorts is warranted to determine optimal subsequent options, for example, thermal radiofrequency of the ganglion impar or sacrococcygeal nerves, or chemical neurolysis, following an initial response to a ganglion impar block or PRF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.